LEI: 549300Q7EXQQH6KF7Z84

19 August 2021

RTW Venture Fund Limited

Notice of Interim Report

RTW Venture Fund Limited (the "Company") advises that it will publish its Interim Report for the six months ended 30 June 2021 (the "Interim Report") on 16 September 2021.

A conference call for analysts and sales teams will be held at 2 pm BST / 9 am EST on the day. To register for the event please RSVP to georgeb@buchanan.uk.com.

For Further Information

RTW Investments, LP                                        +1 (646) 343 9280
Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations

Julia Enright, Business Development Associate

Buchanan                                                          +44 (0)20 7466 5000
Charles Ryland

Henry Wilson

George Beale

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading US healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.